Skip to main content

Table 1 Demographics and Tumor characteristics of patients

From: The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly

Variable

Group A (≥ 70 y) (N = 23)

Group B (<  70 y) (N = 58)

p-value

Age (years) mean ± SD

74.9 ± 3.4

50.9 ± 12.7

0.003*

Gender (M/F)

21/2

46/12

0.329

BMI (kg/m2) mean ± SD

22.7 ± 3.1

22.3 ± 2.9

0.586

ASA score

 I/II

16

53

0.137

 III

7 (30.4%)

5(9.4%)

0.047

ICGR 15(%) mean ± SD

11.8 ± 4.5

10.3 ± 3.9

0.129

Album g/dl

3.65 ± 0.5

3.84 ± 0.48

0.231

Total bilirubin mg/d

0.83 ± 0.5

0.87 ± 0.46

0.625

Comorbidity (present/absent)

 Cardiac diseases n (%)

4 (17.4)

1 (1.7)

0.041*

 Diabetes n (%)

2 (8.7)

4 (6.9)

0.780

 Hypertension n (%)

7 (30.4)

6 (10.3)

0.551

 COPD n (%)

3 (13.0)

1 (1.7)

0.067

 Cirrhosis n (%)

4 (17.4)

12 (20.6)

0.078

Child-Pugh classification A/B/C

91.3/ 8.7/0

82.8/ 17.2/0

0.493

HBV n (%)

12 (52.2)

37 (63.8)

0.450

Tumor size (cm)

4.7 ± 2.0

3.7 ± 2.1

0.403

Tumor size ≥5 cm n (%)

7 (30.4)

14 (24.1)

0.582

Tumor number 1/2/≥3 (%)

95.7/ 4.3/ 0

87.9/ 8.6/ 3.4

0.520

UICC7

  

0.882

 Stage I

12 (52.17%)

37(63.79%)

 

 Stage II

5 (21.73%)

6(10.34%)

 

 Stage IIIA

5(21.73%)

12(20.69%)

 

 Stage IIIB

1(4.34%)

2(3.45%)

 

 Stage IIIC

0

1(1.72%)

 

Previous abdominal operation n (%)

10 (43.5)

16 (27.6)

0.193

Extent of live resection

  

0.388

 Wedge n (%)

4 (17.39)

18 (31.03)

 

 Segmentectomy n (%)

15(65.21)

28(50.90)

 

 Hemihepatectomy n (%)

4 (17.39)

12(20.68)

 
  1. HCC Hepatocellular carcinoma, BMI body mass index, ASA American Society of Anesthesiology
  2. *: P value < 0.05